Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Exerkine Logo
Exerkine (closed)
Exerkine Corporation is a biotech-pharmaceutical company that is developing highly effective new therapies to treat a variety of genetic.
Closed Founded
obfuscation
PrivateFunding Round Hamilton, Ontario, Canada11-50 www.exerkine.com/
Biotechnology

Exerkine is permanently closed. If you feel this is an error, let us know.

Overview

Exerkine
Heat Score
51

Growth Score
pts
in past quarter
Heat Score 51
-14 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Exerkine

Exerkine Corporation is a biotech-pharmaceutical company that is developing highly effective new therapies to treat a variety of genetic.
Closed Founded
obfuscation
PrivateFunding Round Hamilton, Ontario, Canada11-50 www.exerkine.com/
Biotechnology

Funding Rounds

Funding Round
OBF
in
obfuscation

Key People

Details

Operating Status Closed
Company Type For Profit
Founders  MARK TARNOPOLSKY
About the Company

Exerkine Corporation is a biotech-pharmaceutical company that is developing highly effective new therapies to treat a variety of genetic and aging-associated diseases based on recent developments in the understanding of exercise physiology. Our passion for health and fitness are driving efforts to discover, develop and commercialize therapies that

will ameliorate or cure many genetic diseases.

Contact Email info@exerkine.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - Exerkine Logo
Funding Round - Exerkine
1
obfuscation
— Funding Round
obfuscation
Funding Round - Exerkine Logo
Funding Round - Exerkine
1
obfuscation
— Funding Round
obfuscation
Funding Round - Exerkine Logo
Funding Round - Exerkine
1
obfuscation
— Funding Round
obfuscation
Funding Round - Exerkine Logo
Funding Round - Exerkine
1
obfuscation
— Funding Round
obfuscation
Funding Round - Exerkine Logo
Funding Round - Exerkine
1
obfuscation
— Funding Round

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - Exerkine Logo
Funding Round - Exerkine
1
obfuscation
— Funding Round
obfuscation
Funding Round - Exerkine Logo
Funding Round - Exerkine
1
obfuscation
— Funding Round
obfuscation
Funding Round - Exerkine Logo
Funding Round - Exerkine
1
obfuscation
— Funding Round
obfuscation
Funding Round - Exerkine Logo
Funding Round - Exerkine
1
obfuscation
— Funding Round
obfuscation
Funding Round - Exerkine Logo
Funding Round - Exerkine
1
obfuscation
— Funding Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Photo of Fady Hannah-Shmouni, MD FRCPC
Fady Hannah-Shmouni, MD FRCPC
No
Funding Round - Exerkine Logo
Funding Round - Exerkine
—
Photo of Fady Hannah-Shmouni, MD FRCPC
Fady Hannah-Shmouni, MD FRCPC
No
Funding Round - Exerkine Logo
Funding Round - Exerkine
—
Photo of Fady Hannah-Shmouni, MD FRCPC
Fady Hannah-Shmouni, MD FRCPC
No
Funding Round - Exerkine Logo
Funding Round - Exerkine
—
Photo of Fady Hannah-Shmouni, MD FRCPC
Fady Hannah-Shmouni, MD FRCPC
No
Funding Round - Exerkine Logo
Funding Round - Exerkine
—
Photo of Fady Hannah-Shmouni, MD FRCPC
Fady Hannah-Shmouni, MD FRCPC
No
Funding Round - Exerkine Logo
Funding Round - Exerkine
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News

News and Press

News•Oct 17, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$448.7KThis year, Exerkine is projected to spend $448.7K on IT, according to Aberdeen.

Active Website Tech Count

8Exerkine is actively using 8 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, Microsoft Azure, and  ASP.NET Core.

Total IP

31The intellectual property of Exerkine includes 25 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Exerkine has registered 6 trademarks with the most popular class being 'Education; entertainment', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Exerkine's headquarters? Exerkine is located in Hamilton, Ontario, Canada.Who invested in Exerkine? Exerkine is funded by Fady Hannah-Shmouni, MD FRCPC.When was the last funding round for Exerkine? Exerkine closed its last funding round on
obfuscation
from a Undisclosed round.Who are Exerkine's competitors? Alternatives and possible competitors to Exerkine may include BioMarin Pharmaceutical, Intellia Therapeutics, and  Editas Medicine.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|